Serenity Treatment Center, Inc.
Serenity Treatment Center, Inc.
  • Home
  • About
    • Overview
    • Staff
  • Services
    • Program Overview
    • What To Expect
    • DUI/DWI Education
    • Traditional Outpatient
    • Intensive Outpatient
    • Vivitrol
    • Bridge and MAT
  • Locations
    • Frederick
    • Hagerstown
  • Payments & Scheduling
    • Scheduling
    • Payments
  • Referral Forms
  • Contact Us
  • Subscribe
  • Careers
  • More
    • Home
    • About
      • Overview
      • Staff
    • Services
      • Program Overview
      • What To Expect
      • DUI/DWI Education
      • Traditional Outpatient
      • Intensive Outpatient
      • Vivitrol
      • Bridge and MAT
    • Locations
      • Frederick
      • Hagerstown
    • Payments & Scheduling
      • Scheduling
      • Payments
    • Referral Forms
    • Contact Us
    • Subscribe
    • Careers
  • Home
  • About
    • Overview
    • Staff
  • Services
    • Program Overview
    • What To Expect
    • DUI/DWI Education
    • Traditional Outpatient
    • Intensive Outpatient
    • Vivitrol
    • Bridge and MAT
  • Locations
    • Frederick
    • Hagerstown
  • Payments & Scheduling
    • Scheduling
    • Payments
  • Referral Forms
  • Contact Us
  • Subscribe
  • Careers

Bridge and MAT

Bridge is the first FDA-cleared, drug-free, non-surgical device to use neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. 


We are pleased to have partnered with other community providers who will be seeing clients/non-clients for evaluations, medication management and MAT with Lucemyra, Suboxone and Vivitrol.  Please call 301-898-2627 for more information.


To learn more:

Masimo - Bridge 

https://youtu.be/P4dDDwYwu4Y 

A Non-Addictive Opioid Withdrawal Treatment | LUCEMYRA (lofexidine) 


If you are interested give us a call to learn more or speak to the on-site Nurse.


Copyright © 2023 Serenity Treatment Center, Inc. - All Rights Reserved.


Powered by GoDaddy Website Builder

Check us out on Facebook!

Don't forget to subscribe to our newsletter!

Learn more